EARNEST Partners LLC recently announced the acquisition of new stake in Houlihan Lokey Inc. (NYSE:HLI). The institutional investor has increased its shareholding in the Financial company by 0.73% to 3.69 million shares with purchase of 26657.0 shares. This fresh investment now brings its stake to 7.40% valued currently at $321.31 million. In addition, T. Rowe Price Investment Manageme raised its holdings by 1.36 million to 1.36 million shares. And Managed Account Advisors LLC has lifted its position by 0.30% or 3512.0 shares – to 1.19 million shares.
With over 0.31 million Houlihan Lokey Inc. (HLI) shares trading Friday and a closing price of $97.91 on the day, the dollar volume was approximately $29.97 million. The shares have shown a positive half year performance of 25.67% and its price on 01/13/23 gained nearly 1.72%. Currently, there are 63.42M common shares owned by the public and among those 49.79M shares have been available to trade.
Insiders at the company have transacted a total of 22 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 14 of these insider trades were purchases, accounting for 46,308 shares. Insider sales of the common stock occurred on 8 occasions, with total insider shares sold totaling 42,256 shares.
The top 3 mutual fund holders in Houlihan Lokey Inc. are Vanguard Total Stock Market Index, Vanguard Small Cap Index Fund, and iShares Russell 2000 ETF. Vanguard Total Stock Market Index owns 1.49 million shares of the company’s stock, all valued at over $130.0 million. The company bought an additional 1755.0 shares recently to bring their total holdings to about 2.99% of the shares outstanding. Vanguard Small Cap Index Fund bought 1606.0 shares to see its total holdings expand to 1.28 million shares valued at over $111.84 million and representing 2.57% of the shares outstanding. iShares Russell 2000 ETF sold 11590.0 shares to bring its total holdings to over 1.11 million shares at a value of $97.05 million. iShares Russell 2000 ETF now owns shares totaling to 2.23% of the shares outstanding.
Shares of Houlihan Lokey Inc. (NYSE: HLI) opened at $95.53, down -$0.72 from a prior closing price of $96.25. However, the script later moved the day high at 98.49, up 1.72%. The company’s stock has a 5-day price change of 8.33% and 19.69% over the past three months. HLI shares are trading 12.33% year to date (YTD), with the 12-month market performance down to -18.09% lower. It has a 12-month low price of $74.18 and touched a high of $121.19 over the same period. HLI has an average intraday trading volume of 327.82K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 8.33%, 4.38%, and 14.96% respectively.
Institutional ownership of Houlihan Lokey Inc. (NYSE: HLI) 63.42M shares outstanding. Mutual fund holders own 53.63%, while other institutional holders and individual stakeholders account for 6.95% and 46.69% respectively.
It has a market capitalization of $6.61B and a beta (3y monthly) value of 0.77. The stock’s trailing 12-month PE ratio is 18.10, while the earnings-per-share (ttm) stands at $5.41. The company has a PEG of 2.08 and the debt-to-equity ratio at 0.00. Price movements for the stock have been influenced by the stock’s volatility, which stands at 3.18% over the week and 2.61% over the month.
Analysts forecast that Houlihan Lokey Inc. (HLI) will achieve an EPS of $1.39 for the current quarter, $1.39 for the next quarter and $5.76 for 2024. The lowest estimate earnings-per-share for the quarter is $1.04 while analysts give the company a high EPS estimate of $1.73. Comparatively, EPS for the current quarter was $2.9 a year ago. Earnings per share for the fiscal year are expected to increase by 40.80%, and 18.73% over the next financial year. EPS should shrink at an annualized rate of 8.70% over the next five years, compared to 31.60% over the past 5-year period.
Looking at the support for the HLI, a number of firms have released research notes about the stock. Morgan Stanley stated their Equal-Weight rating for the stock in a research note on July 18, 2022, with the firm’s price target at $95-$82. Piper Sandler coverage for the Houlihan Lokey Inc. (HLI) stock in a research note released on April 07, 2022 offered a Underweight rating with a price target of $76. Goldman was of a view on January 06, 2022 that the stock is Buy, while UBS gave the stock Buy rating on January 04, 2022, issuing a price target of $120- $116. Keefe Bruyette on their part issued Mkt Perform rating on October 29, 2021.